10 Mg Lenvatinib Capsules IP

Name: 10 Mg Lenvatinib Capsules IP
Brand: NEETCO BIOPHARMA
Price: 2299 INR
Availability: InStock

Price 2299 INR/ Box

Get a Price/Quote

MOQ : 1 Box

10 Mg Lenvatinib Capsules IP Specification

Indication
Used in the treatment of thyroid cancer and certain other types of cancer

Dosage Form
Capsules

Salt Composition
Lenvatinib 10 mg

Feature
Readily dissolves for rapid release of drug

Ingredients
Lenvatinib Mesylate and excipients

Application
Oral anti-cancer therapy

Physical Color/Texture
Opaque white body with a green cap, containing white to off-white powder

Fermentation Smell
Odorless or faint medicinal smell

Storage Instructions
Store below 30C, protect from light and moisture

Shelf Life
24 months

ATC Code
L01EX10

Prescription Status
Prescription Only Medicine

Route of Administration
Oral

Regulatory Status
Manufactured under GMP-certified facility

Packaging Type
Blister pack, 1 strip of 10 capsules per box

Strength
10 mg per capsule

Container Material
Aluminium-PVC blister

About 10 Mg Lenvatinib Capsules IP

Access the crowning standard in oral anti-cancer therapy with our 10 Mg Lenvatinib Capsules IP. Every blister pack holds a customizable strip of 10 capsules, featuring unmatchable efficacy and rapid dissolution for swift drug release. Special rates are offered for distributors, exporters, suppliers, and traders across India. Manufactured in a preeminent, GMP-certified facility, these capsules come securely packaged in Aluminium-PVC blisters, safeguarding stability and potency. Indicated for thyroid cancer and certain others, Lenvatinib delivers precise treatment excellence. Trust our product for quality, reliability, and regulatory assurance.

Targeted Therapy for Thyroid Cancer and Beyond

10 Mg Lenvatinib Capsules IP is specifically formulated for oral treatment of thyroid cancer and select advanced cancers. Its advanced delivery ensures thorough absorption, making it an invaluable option for patients in need of preeminent targeted therapy. With its customizable dosage form and unmatchable release profile, this medication proves vital in providing effective, rapid intervention. Professionals recognize its application across several malignancies, ensuring a tailored solution for diverse patient requirements in clinical oncology.

Streamlined Payments and Reliable Distribution

Our payment terms offer flexibility, with secure logistics and order processing designed for efficiency. Sample requests are welcomed for qualifying buyers, making product evaluation simple and transparent. With robust supply ability, we ensure prompt, secure shipping and timely delivery to any location. We prioritize seamless coordination, from procurement to transport, to guarantee satisfaction for distributors and healthcare providers seeking trusted oral anti-cancer therapies throughout India and abroad.

FAQ's of 10 Mg Lenvatinib Capsules IP:

Q: How should 10 Mg Lenvatinib Capsules IP be stored to maintain its quality?

A: Store the capsules below 30C, protected from light and moisture, in their original Aluminium-PVC blister packaging to ensure shelf life and drug potency.

Q: What are the main usage indications for this medication?

A: Lenvatinib Capsules 10 mg are primarily indicated for the treatment of thyroid cancer and may be used for certain other types of advanced cancers as prescribed by a specialist.

Q: Where is this product manufactured and what regulations are followed?

A: This medication is manufactured in India under a GMP-certified facility, adhering strictly to international quality and safety guidelines for pharmaceutical production.

Q: When can samples be requested and how is the order processed?

A: Samples are available upon request for eligible buyers. Once your order is confirmed, our team manages logistics and secure shipping to ensure timely delivery and product integrity.

Q: What benefits does the rapid-release feature of Lenvatinib capsules offer?

A: The capsules are designed to dissolve readily, allowing a swift release of Lenvatinib, which supports prompt therapeutic action and improved patient outcomes.

Tell us about your requirement